Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Free
Faster access than browser!
 

Afamelanotide

Index Afamelanotide

Afamelanotide ((INN) (brand name Scenesse), also known as melanotan I (or melanotan-1), originally developed at the University of Arizona and now by Clinuvel Pharmaceuticals, is a synthetic peptide and analogue of the naturally occurring melanocortin peptide hormone α-melanocyte stimulating hormone (α-MSH) that has been shown to induce the production of darkening dermal pigmentation through melanogenesis and thereby subsequently reduce sun (UV) damage to UV light-exposed skin in preliminary research and human clinical trials. Its amino acid sequence is Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2, and it is additionally known as -α-MSH, which is sometimes abbreviated as NDP-MSH or NDP-α-MSH (especially in the scientific literature). Afamelanotide is the International Nonproprietary Name for the molecule α-MSH initially researched and developed as melanotan-1 and later, CUV1647 (by Clinuvel). A marketing trade name for one brand of afamelanotide was approved in 2010 by the European Medicines Agency (EMA) Name Review Group (NRG) and the agency's Committee for Medicinal Products for Human Use (CHMP) as Scenesse (pronounced "sen-esse"). On May 5, 2010 the Italian Medicines Agency (AIFA, or Agenzia Italiana del Farmaco) became the first governmental health organization ever (even before the drug received approval in Europe) to authorize afamelanotide as a medicine for therapeutic treatment of Italian citizens to reduce painful dermal photosensitivity stemming from the orphan disease erythropoietic protoporphyria (EPP). This approval allowed the drug to be immediately available for prescription in Italy and reimbursable under the country's national health system. Authorities in Switzerland have also allowed prescription of the drug for EPP with reimbursement approved by two unnamed insurers. Afamelanotide is currently being trialed in the form of a "grain of rice"-sized bioabsorbable subcutaneous implant as a potential therapeutic photoprotection-inducing agent for a series of light-related skin indications as well as a potential dermal repigmentation agent for vitiligo. Afamelanotide, as of October 24, 2014, has been approved by the EMA in Europe for the treatment of EPP. Clinuvel now intends to seek approval of afamelanotide in the United States. Unlicensed and untested powders sold as "melanotan" are found on the Internet and are reported to be used by tens of thousands of members of the general public for sunless tanning. Multiple regulatory bodies have warned consumers that the peptides may be unsafe and ineffective in usage, with one regulatory agency warning that consumers who purchase any product labeled "melanotan" risk buying a counterfeit drug. Clinuvel Pharmaceuticals, the developer of afamelanotide, and medical researchers have warned consumers that counterfeit products sold using the names "melanotan I and II", could "pose a hazard to public health". on counterfeit products. February 10, 2009. Clinuvel has stated publicly that products sold online as "melanotan" are not afamelanotide. [1]

24 relations: Actinic keratosis, Alpha-Melanocyte-stimulating hormone, ATC code D02, BMS-470539, Bremelanotide, Erythropoietic protoporphyria, Hives, List of compounds with carbon numbers 50–100, List of designer drugs, List of drugs: Ad-Ak, Melanocortin 1 receptor, Melanocortin 4 receptor, Melanocortin receptor, Melanocyte-stimulating hormone, Melanotan, Melanotan II, Methoxsalen, Modimelanotide, Porphyria, Proopiomelanocortin, Setmelanotide, Skin whitening, Sunless tanning, Vitiligo.

Actinic keratosis

Actinic keratosis (AK) is a pre-cancerous patch of thick, scaly, or crusty skin.

New!!: Afamelanotide and Actinic keratosis · See more »

Alpha-Melanocyte-stimulating hormone

α-Melanocyte-stimulating hormone (α-MSH) is an endogenous peptide hormone and neuropeptide of the melanocortin family, with a tridecapeptide structure and the amino acid sequence Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2.

New!!: Afamelanotide and Alpha-Melanocyte-stimulating hormone · See more »

ATC code D02

D02.

New!!: Afamelanotide and ATC code D02 · See more »

BMS-470539

BMS-470539 is a small-molecule experimental drug which acts as a potent and highly selective full agonist of the MC1 receptor.

New!!: Afamelanotide and BMS-470539 · See more »

Bremelanotide

Bremelanotide (tentative brand name Rekynda; former developmental code name PT-141) is a peptide melanocortin receptor agonist which is under development by Palatin Technologies as a treatment for female sexual dysfunction.

New!!: Afamelanotide and Bremelanotide · See more »

Erythropoietic protoporphyria

Erythropoietic protoporphyria (EPP) is a form of porphyria, which varies in severity and can be very painful.

New!!: Afamelanotide and Erythropoietic protoporphyria · See more »

Hives

Hives, also known as urticaria, is a kind of skin rash with red, raised, itchy bumps.

New!!: Afamelanotide and Hives · See more »

List of compounds with carbon numbers 50–100

This is a partial list of molecules that contain 50 to 100 carbon atoms.

New!!: Afamelanotide and List of compounds with carbon numbers 50–100 · See more »

List of designer drugs

Designer drugs are structural or functional analogues of controlled substances that are designed to mimic the pharmacological effects of the parent drug while avoiding detection or classification as illegal.

New!!: Afamelanotide and List of designer drugs · See more »

List of drugs: Ad-Ak

No description.

New!!: Afamelanotide and List of drugs: Ad-Ak · See more »

Melanocortin 1 receptor

The melanocortin 1 receptor (MC1R), also known as melanocyte-stimulating hormone receptor (MSHR), melanin-activating peptide receptor, or melanotropin receptor, is a G protein–coupled receptor that binds to a class of pituitary peptide hormones known as the melanocortins, which include adrenocorticotropic hormone (ACTH) and the different forms of melanocyte-stimulating hormone (MSH).

New!!: Afamelanotide and Melanocortin 1 receptor · See more »

Melanocortin 4 receptor

Melanocortin 4 receptor is a protein that in humans is encoded by the MC4R gene.

New!!: Afamelanotide and Melanocortin 4 receptor · See more »

Melanocortin receptor

Melanocortin receptors are members of the rhodopsin family of 7-transmembrane G protein-coupled receptors.

New!!: Afamelanotide and Melanocortin receptor · See more »

Melanocyte-stimulating hormone

The melanocyte-stimulating hormones, known collectively as MSH, also known as melanotropins or intermedins, are a family of peptide hormones and neuropeptides consisting of α-melanocyte-stimulating hormone (α-MSH), β-melanocyte-stimulating hormone (β-MSH), and γ-melanocyte-stimulating hormone (γ-MSH) that are produced by cells in the pars intermedia of the anterior lobe of the pituitary gland.

New!!: Afamelanotide and Melanocyte-stimulating hormone · See more »

Melanotan

Melanotan may refer to one of two separate peptides.

New!!: Afamelanotide and Melanotan · See more »

Melanotan II

Melanotan II is a synthetic analogue of the peptide hormone α-melanocyte-stimulating hormone (α-MSH).

New!!: Afamelanotide and Melanotan II · See more »

Methoxsalen

Methoxsalen (also called xanthotoxin, marketed under the trade names Oxsoralen, Deltasoralen, Meladinine) is a drug used to treat psoriasis, eczema, vitiligo, and some cutaneous lymphomas in conjunction with exposing the skin to UVA light from lamps or sunlight.

New!!: Afamelanotide and Methoxsalen · See more »

Modimelanotide

Modimelanotide (INN) (code names AP-214, ABT-719, ZP-1480) is a melanocortinergic peptide drug derived from α-melanocyte-stimulating hormone (α-MSH) which was under development by, at different times, Action Pharma, Abbott Laboratories, AbbVie, and Zealand for the treatment of acute kidney injury.

New!!: Afamelanotide and Modimelanotide · See more »

Porphyria

Porphyria is a group of diseases in which substances called porphyrins build up, negatively affecting the skin or nervous system.

New!!: Afamelanotide and Porphyria · See more »

Proopiomelanocortin

Pro-opiomelanocortin (POMC) is a precursor polypeptide with 241 amino acid residues.

New!!: Afamelanotide and Proopiomelanocortin · See more »

Setmelanotide

Setmelanotide (INN, USAN; development codes RM-493, BIM-22493, IRC-022493) is a peptide drug and investigational anti-obesity medication which acts as a selective agonist of the MC4 receptor.

New!!: Afamelanotide and Setmelanotide · See more »

Skin whitening

Skin whitening is the practice of using substances, mixtures, or physical treatments to lighten skin color.

New!!: Afamelanotide and Skin whitening · See more »

Sunless tanning

Sunless tanning, also known as UV filled tanning, self tanning, spray tanning (when applied topically), or fake tanning, refers to the application of chemicals to the skin to produce an effect similar in appearance to a suntan.

New!!: Afamelanotide and Sunless tanning · See more »

Vitiligo

Vitiligo is a long-term skin condition characterized by patches of the skin losing their pigment.

New!!: Afamelanotide and Vitiligo · See more »

Redirects here:

ATC code D02BB02, ATCvet code QD02BB02, Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2, C78H111N21O19, CUV1647, EPT1647, Melanotan 1, Melanotan I, Melanotan-1, Melanotan-I, NDP-MSH, NDP-a-MSH, NDP-alpha-MSH, NDP-α-MSH, Nle4,D-Phe7-α-MSH, Nle4,d-Phe7-α-MSH, Scenesse.

References

[1] https://en.wikipedia.org/wiki/Afamelanotide

OutgoingIncoming
Hey! We are on Facebook now! »